The missing layer in
real-world evidence
RWEengine™ captures physician intent and clinical confidence before a prescription is written — not months after it appears in claims.
Claims data lags 3–6 months. By the time it appears, the decision is already over. RWEengine™ operates upstream — at the moment decisions are formed.
DUPIXENT® Intelligence
Atopic Dermatitis · Sanofi / Regeneron
Adoption Stack
Trending Signals
Full access for authorized partners only
Claims data tells you
what already happened
RWEengine™ operates upstream of the prescription — capturing physician intent, clinical confidence, and peer dynamics at the moment decisions are formed.
Six signals that don't
exist in claims data
Every score is derived from real physician input — not modeled, not inferred, not lagging.
Therapy Value Index
A composite real-time score reflecting perceived clinical and practical value, dynamically updated from physician input across efficacy, safety, adherence, access, and usability.
Relative Value Index
Head-to-head competitive positioning versus alternatives in the same indication. Detects differentiation or erosion early — before market share shifts appear in any claims dataset.
Prescribing Likelihood Score
Predictive probability of near-term prescribing in 30–90 days, driven by clinical confidence, peer alignment, access friction, and live engagement signals. This metric does not exist in claims.
Clinical Confidence Index
Measures prescriber certainty and comfort using a therapy in real-world patients. Serves as an early warning for adoption slowdowns and a leading indicator of guideline divergence.
Prescriber Advocacy Score
Quantifies peer-to-peer influence and recommendation behavior. Captures propagation potential across physician networks and surfaces momentum beyond individual prescribers.
Barrier Intelligence
Real-time visibility into why adoption stalls — PA burden, payer friction, safety concerns, adherence drop-off, and regional variation — months before they appear in utilization data.
Early signal access.
Before approval.
RWEengine™ captures prescriber awareness, interest, and intent signals during the pre-approval window — not just after launch. Your intelligence layer is already primed when Day 1 arrives.
Awareness & Interest Signals
Physician awareness, peer discussion, and early clinical interest tracked before the Rx is even possible.
TVI™, RVI™ & PLS Go Live
All pre-launch signals prime the core metrics — so Day 1 intelligence reflects weeks of accumulated prescriber sentiment.
Continuous Adoption Intelligence
The intelligence layer never resets. Barrier signals, competitive shifts, and advocacy scores update in real time as adoption evolves.
“Pre-launch signals feed directly into TVI™, RVI™, and Prescribing Likelihood Scores — creating a continuous intelligence layer from pre-approval through post-launch adoption.”
Authorized partner access
at every scale
RWEengine™ is available exclusively to vetted partners in pharma, HEOR, and healthcare analytics. Contact us to verify eligibility.
Essentials
per engagement
Single-product intelligence
- TVI™ & RVI™ for 1 therapy
- Prescribing Likelihood Score
- Barrier Intelligence dashboard
- Quarterly reporting cadence
- Competitive benchmarking
- API & data feed access
Intelligence Suite
annual subscription
Full platform · multi-therapy coverage
- All six live intelligence metrics
- Multi-therapy & competitive RVI™
- Real-time dashboard access
- Specialty & regional segmentation
- Trend alerts & launch signals
- Dedicated account management
Enterprise
enterprise licensing
API · HEOR · Data licensing
- Everything in Intelligence Suite
- Raw data API & feed access
- Custom HEOR study design
- White-label licensing options
- Unlimited therapeutic areas
- Executive strategy support
Access your
intelligence dashboard
View real-time prescriber signals, adoption drivers, and competitive positioning for your product portfolio — updated daily from live physician data.
- Full 6-metric intelligence dashboard
- Adoption Stack analytics
- Barrier Intelligence with trending
- Specialty & geography segmentation
Sign in
Access restricted to authorized partners